2016, Número 2
<< Anterior Siguiente >>
Rev Med MD 2016; 7.8 (2)
Obesity and kidney disease: hidden consequences of the epidemic
Kovesdy CP, Furth S, Zoccali C
Idioma: Ingles.
Referencias bibliográficas: 88
Paginas: 39-45
Archivo PDF: 7538.60 Kb.
FRAGMENTO
Sin resumen.
REFERENCIAS (EN ESTE ARTÍCULO)
Forouzanfar MH, Alexander L, Anderson HR, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:2287-2323, 2015
Flegal KM, Kruszon-Moran D, Carroll MD, et al.: Trends in Obesity Among Adults in the United States, 2005 to 2014. JAMA 315:2284-2291, 2016
Cattaneo A, Monasta L, Stamatakis E, et al. Overweight and obesity in infants and pre-school children in the European Union: a review of existing data. Obes Rev 11:389-398, 2010
Olaya B, Moneta MV, Pez O, Bitfoi A, et al. Countrylevel and individual correlates of overweight and obesity among primary school children: a crosssectional study in seven European countries. BMC Public Health 15:475, 2015
Subramanian SV, Perkins JM, Ozaltin E, Davey SG: Weight of nations: a socioeconomic analysis of women in low- to middle-income countries. Am J Clin Nutr 93:413-421, 2011
Tsujimoto T, Sairenchi T, Iso H, et al. The doseresponse relationship between body mass index and the risk of incident stage >/=3 chronic kidney disease in a general japanese population: the Ibaraki prefectural health study (IPHS). J Epidemiol 24:444- 451, 2014
Elsayed EF, Sarnak MJ, Tighiouart H, et al. Waist-tohip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 52:29-38, 2008
Pinto-Sietsma SJ, Navis G, Janssen WM, de ZD, Gans RO, de Jong PE: A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41:733-741, 2003
Foster MC, Hwang SJ, Larson MG, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis 52:39-48, 2008
Kramer H, Luke A, Bidani A, et al. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am J Kidney Dis 46:587-594, 2005
Chang A, Van HL, Jacobs DR, Jr., Liu K, et al. Lifestyle-related factors, obesity, and incident microalbuminuria: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Am J Kidney Dis 62:267-275, 2013
Ejerblad E, Fored CM, Lindblad P, et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol 17:1695-1702, 2006
Gelber RP, Kurth T, Kausz AT, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 46:871-880, 2005
Lu JL, Molnar MZ, Naseer A, et al.Association of age and BMI with kidney function and mortality: a cohort study. Lancet Diabetes Endocrinol 3:704-714, 2015
Munkhaugen J, Lydersen S, Wideroe TE, Hallan S: Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway. Am J Kidney Dis 54:638-646, 2009
Iseki K, Ikemiya Y, Kinjo K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65:1870- 1876, 2004
Vivante A, Golan E, Tzur D, et al. Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med 172:1644-1650, 2012
Hsu C, McCulloch C, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med 144:21-28, 2006
Lu JL, Kalantar-Zadeh K, Ma JZ, et al.Association of body mass index with outcomes in patients with CKD. J Am Soc Nephrol 25:2088-2096, 2014
Thoenes M, Reil JC, Khan BV, et al. Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension. Vasc Health Risk Manag 5:577-585, 2009
Kramer H, Gutierrez OM, Judd SE, et al. Waist Circumference, Body Mass Index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis 67:62- 69, 2016
Foster MC, Hwang SJ, Massaro JM, et al. Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study. Obesity (Silver Spring) 19:1284-1289, 2011
Postorino M, Marino C, Tripepi G, Zoccali C: Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 53:1265-1272, 2009
Kovesdy CP, Czira ME, Rudas A, et al. Body mass index, waist circumference and mortality in kidney transplant recipients. Am J Transplant 10:2644-2651, 2010
Scales CD, Jr., Smith AC, Hanley JM, Saigal CS: Prevalence of kidney stones in the United States. Eur Urol 62:160-165, 2012
Curhan GC, Willett WC, Rimm EB, et al. Body size and risk of kidney stones. J Am Soc Nephrol 9:1645- 1652, 1998
Taylor EN, Stampfer MJ, Curhan GC: Obesity, weight gain, and the risk of kidney stones. JAMA 293:455-462, 2005
Bhaskaran K, Douglas I, Forbes H, et al. Bodymass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 384:755-765, 2014
Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol 16:36-46, 2015
Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569-578, 2008
Bluher M: The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 21:38-43, 2010
Sharma K: The link between obesity and a l b u m i n u r i a : a d i p o n e c t i n a n d p o d o c y t e dysfunction. Kidney Int 76:145-148, 2009
Wolf G, Ziyadeh FN: Leptin and renal fibrosis. Contrib Nephrol 151:175-183, 2006
Ellington AA, Malik AR, Klee GG, et al. Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults. Hypertension 50:708-714, 2007
Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17:4-12, 2006
Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752-1761, 2004
Ruan XZ, Varghese Z, Moorhead JF: An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol 5:713-721, 2009
Ruster C, Wolf G: The role of the reninangiotensin- aldosterone system in obesity-related renal diseases. Semin Nephrol 33:44-53, 2013
Oterdoom LH, de Vries AP, Gansevoort RT, et al. Fasting insulin modifies the relation between age and renal function. Nephrol Dial Transplant 22:1587- 1592, 2007
Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59:1498-1509, 2001
de Vries AP, Ruggenenti P, Ruan XZ, et al. Fatty kidney: emerging role of ectopic lipid in obesityrelated renal disease. Lancet Diabetes Endocrinol 2:417-426, 2014
Foster MC, Hwang SJ, Porter SA, et al. Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension 58:784- 790, 2011
Henegar JR, Bigler SA, Henegar LK, et al.Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 12:1211-1217, 2001
Knight SF, Quigley JE, Yuan J, et al. Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet. Hypertension 51:352-359, 2008
Tsuboi N, Utsunomiya Y, Kanzaki G, et al. Low glomerular density with glomerulomegaly in obesity-related glomerulopathy. Clin J Am Soc Nephrol 7:735-741, 2012
Ribstein J, du CG, Mimran A: Combined renal effects of overweight and hypertension. Hypertension 26:610-615, 1995
Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY: Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65:1422-1425, 2004
Lemann J, Jr., Pleuss JA, Worcester EM, et al. Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. Kidney Int 49:200-208, 1996
Siener R, Glatz S, Nicolay C, Hesse A: The role of overweight and obesity in calcium oxalate stone formation. Obes Res 12:106-113, 2004
Taylor EN, Stampfer MJ, Curhan GC: Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68:1230-1235, 2005
Klisic J, Hu MC, Nief V, et al. Insulin activates Na(+)/H(+) exchanger 3: biphasic response and glucocorticoid dependence. Am J Physiol Renal Physiol 283:F532-F539, 2002
Chobanian MC, Hammerman MR: Insulin stimulates ammoniagenesis in canine renal proximal tubular segments. Am J Physiol 253:F1171- F1177, 1987
Daudon M, Lacour B, Jungers P: Influence of body size on urinary stone composition in men and women. Urol Res 34:193-199, 2006
Sinha MK, Collazo-Clavell ML, Rule A, et al.Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 72:100-107, 2007
Calle EE, Kaaks R: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579-591, 2004
Dalamaga M, Diakopoulos KN, Mantzoros CS: The role of adiponectin in cancer: a review of current evidence. Endocr Rev 33:547-594, 2012
Lamas O, Marti A, Martinez JA: Obesity and immunocompetence. Eur J Clin Nutr 56 Suppl 3:S42- S45, 2002
Lim C, Savan R: The role of the IL-22/IL-22R1 axis in cancer. Cytokine Growth Factor Rev 25:257- 271, 2014
Grivennikov SI, Greten FR, Karin M: Immunity, inflammation, and cancer. Cell 140:883-899, 2010
Kovesdy CP, Anderson JE, Kalantar-Zadeh K: Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis 49:581-591, 2007
Kalantar-Zadeh K, Kuwae N, Wu DY, et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 83:202-210, 2006
Beddhu S, Pappas LM, Ramkumar N, et al. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 14:2366- 2372, 2003
Curtis JP, Selter JG, Wang Y, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165:55-61, 2005
Wilson DO, Rogers RM, Wright EC, Anthonisen NR: Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 139:1435-1438, 1989
Escalante A, Haas RW, del R, I: Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 165:1624-1629, 2005
Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, Wu DY: Reverse epidemiology: a spurious hypothesis or a hardcore reality? Blood Purif 23:57-63, 2005
Noori N, Kopple JD, Kovesdy CP, et al. Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 5:2258-2268, 2010
Dekker FW, de MR, van Dijk PC, et al. Survival analysis: time-dependent effects and time-varying risk factors. Kidney Int 74:994-997, 2008
Snyder JJ, Foley RN, Gilbertson DT, et al. Body size and outcomes on peritoneal dialysis in the United States. Kidney Int 64:1838-1844, 2003
Lee PS, Sampath K, Karumanchi SA, et al. Plasma gelsolin and circulating actin correlate with hemodialysis mortality. J Am Soc Nephrol 20:1140- 1148, 2009
Horwich TB, Fonarow GC, Hamilton MA, et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38:789- 795, 2001
Stenvinkel P, Marchlewska A, Pecoits-Filho R, et al. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 65:274-281, 2004
Mohamed-Ali V, Goodrick S, Bulmer K, et al. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 277:E971-E975, 1999
Rauchhaus M, Coats AJ, Anker SD: The endotoxin-lipoprotein hypothesis. Lancet 356:930- 933, 2000
Jandacek RJ, Anderson N, Liu M, et al. Effects of yo-yo diet, caloric restriction, and olestra on tissue distribution of hexachlorobenzene. Am J Physiol Gastrointest Liver Physiol 288:G292-G299, 2005
Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol 17:1453-1459, 2006
Postorino M, Mancini E, D'Arrigo G, et al. Body mass index trend in haemodialysis patients: the shift of nutritional disorders in two Italian regions. Nephrol Dial Transplant 2016
2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. 2009. World Health Organization.
O'Donoghue DJ, Stevens PE: A decade after the KDOQI CKD/guidelines: a perspective from the United Kingdom. Am J Kidney Dis 60:740-742, 2012
Bolignano D, Zoccali C: Effects of weight loss on renal function in obese CKD patients: a systematic review. Nephrol Dial Transplant 28 Suppl 4:iv82-iv98, 2013
Chang Y, Ryu S, Choi Y, et al. Metabolically Healthy Obesity and Development of Chronic Kidney Disease: A Cohort Study. Ann Intern Med 164:305-312, 2016
Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369:145-154, 2013
Mallamaci F, Ruggenenti P, Perna A, et al. ACE inhibition is renoprotective among obese patients with proteinuria. J Am Soc Nephrol 22:1122-1128, 2011
Friedman AN, Wolfe B: Is Bariatric Surgery an Effective Treatment for Type II Diabetic Kidney Disease? Clin J Am Soc Nephrol 11:528-535, 2016
Chang AR, Chen Y, Still C, et al. Bariatric surgery is associated with improvement in kidney outcomes. Kidney Int 90:164-171, 2016
Jamal MH, Corcelles R, Daigle CR, et al. Safety and effectiveness of bariatric surgery in dialysis patients and kidney transplantation candidates. Surg Obes Relat Dis 11:419-423, 2015
Ahmadi SF, Zahmatkesh G, Ahmadi E, Set al. Association of Body Mass Index with Clinical Outcomes in Non-Dialysis-Dependent Chronic Kidney Disease: A Systematic Review and Meta- Analysis. Cardiorenal Med 6:37-49, 2015
Texto completo
Cómo citar este artículo